Table 1.
Demographic and laboratory data in IgAN patients and healthy controls
| IgAN cohort (n = 36) | Healthy cohort (n = 12) | P value | |
|---|---|---|---|
| Mean + SD/ Median (IQR) | Mean + SD/ Median (IQR) | ||
| Age (years) | 45.5 + 13.4 | 46.5 + 13.5 | 0.814 |
| Gender [n, (%)] | |||
| Male | 13 (36%) | 4 (33%) | 0.865 |
| Female | 23 (64%) | 8 (67%) | |
| Race [n, (%)] | |||
| Malay | 17 (47.2%) | 6 (50%) | 0.871 |
| Chinese | 19 (52.8%) | 6 (50%) | |
| BMI (kg/m2) | 24.56 + 2.79 | 23.62 + 3.03 | 0.326 |
| Haemoglobin (g/dL) | 13.43 + 1.56 | 13.18 + 1.54 | 0.707 |
| Urea (mmol/L) | 4.7 (4.2–5.7) | 4.0 (3.4–5.0) | 0.072 |
| Creatinine (μmol/L) | 83.5 (62.3–116.5) | 69.5 (59.3–84.3) | 0.14 |
| eGFR (mls/min/1.73m2) | 79.0 (62.1–92.2) | 86.5 (74.3–93.8) | 0.248 |
| Albumin (g/L) | 41.39 + 3.36 | 42.33 + 1.97 | 0.245 |
| UPCI (g/mmol creatinine) | 0.050 (0.023–0.128) | 0.01 (0.01–0.01) | < 0.001 |
BMI Body Mass Index, eGFR estimated Glomerular Filtration Rate based on CKD EPI 2009
UPCI Urine Protein-Creatinine Index